针对线粒体的I型光药:利用Caspase-3活性进行炎症性瘤治疗
Zhigao Yi1,2, Xujuan Qin3,4, Li Zhang5
1Department of Chemistry, National University of Singapore, Singapore 117543, Singapore.
Journal of the American Chemical Society
|March 20, 2024
概括
这项研究引入了一种新的光动力疗法,使用M-TOP,一种针对线粒体的探针,以控制癌细胞死亡途径. 通过调节亡和亡来增强免疫反应,它有效治疗耐药和缺氧癌症.
科学领域:
- 生物医学工程
- 癌症治疗
- 光动力疗法
背景情况:
- 在癌症治疗中控制细胞死亡是一项挑战.
- 现有的方法缺乏生物相容性和时空控制.
- 调节癌细胞信号提供治疗潜力.
研究的目的:
- 开发一种光动力学策略,精确控制细胞死亡.
- 研究一种针对线粒体的近红外可激活探针 (M-TOP) 用于癌症治疗.
- 探索M-TOP在抗药性和低毒性癌细胞中的有效性.
主要方法:
- 使用了一种类型I光化学机制与线粒体准探针 (M-TOP).
- 用不同剂量的M-TOP调节caspase-3活性和信号交叉.
- 在包括耐药性和低毒性模型在内的多种表达gasdermin- E的癌细胞中测试了疗效.
主要成果:
- 通过caspase-3/ gasdermin- E途径,M-TOP有效调节了亡 (较低剂量) 和高剂量亡.
- 该策略在耐药和缺氧癌细胞中表现出有效性.
- M-TOP诱导了受控的炎症反应,抑制了瘤的生长和复发.
结论:
- 光动力学药物的合理设计可以调节癌症治疗的细胞内信号.
- M-TOP提供了一种控制细胞死亡途径和增强抗瘤免疫力的多功能方法.
- 这种光动力学策略对治疗具有挑战性的癌症和预防复发具有前景.
相关概念视频
Electron Transport Chain: Complex I and II
13.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.2K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


